Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-23

Clinical Trial Update: Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine [Phase 3]

View source ↗

Summary

Phase 3 trial comparing cotrimoxazole prophylaxis to mefloquine for preventing malaria during pregnancy in HIV-infected women; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cotrimoxazole (trimethoprim-sulfamethoxazole)
  • Mefloquine (Mefloquine)

Snippet

Sponsor: Institut de Recherche pour le Developpement | Conditions: Malaria in Pregnancy, HIV Infections | Phase 3 | Status: COMPLETED